Osteonecrosis of bone is a debilitating condition resulting from avascularity of bone. Bisphosphonates which are routinely used in treating bone disorders like osteoporosis and certain malignancies have been associated with increased incidence of osteonecrosis of bone, commonly affecting jaws. Though dental trauma has been a predisposing factor, certain patients have shown spontaneous development of osteonecrosis on long term administration of bisphosphonates.
American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws. J Oral Maxillofacial Surg 2007; 65:369-376.
Rodan GA, Fleisch HA. Bosphosphonates: mechanisms of action. J Clin Invest 1996;97:2692-2696.
Nozari LB, Pacheco VN, Freddo AL, et al. Prevalence of bisphosphonaterelated osteonecrosis of the jaws associated with dental extraction: systematic review. J Dent Maxillofacial Res 2018;1(2):72-77.
Khosla S, Burr D, Cauley J, et al, for the American Society for Bone and Mineral Research. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007;22:1479-1491.
American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate–related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007;5(3):369-376.
Beninati F, Pruneti R, Ficarra G. Bisphosphonate-related osteonecrosis of the jaws (Bronj). Med Oral Patol Oral Cir Bucal 2013 Sep 1;18 (5):e752- 758.
Rasmusson L, Abtahi J. Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment. International Journal of Dentistry 2014;2014.
Kim YG, Lee BS, Kwon YD, et al. Study on bisphosphonate-related osteonecrosis of the jaw (BRONJ): case report and literature review. J Korean Assoc Oral Maxillofac Surg. 2010 Aug;36(4):291-302.
Rodriguez-Lozano FJ, Oñate-Sánchez RE. Treatment of osteonecrosis of the jaw related to bisphosphonates and other antiresorptive agents. Med Oral Patol Oral Cir Bucal 2016 Sep;21(5): e595–e600.
Ripamonti CI, Cislaghi E, Mariani L, et al. Efficacy and safety of medical ozone (O (3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: Preliminary results of a phase I-II study. Oral Oncol 2011;47:185-190.
Atalay B, Yalcin S, Emes Y, et al. Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery? Lasers Med Sci. 2011;26:815-823.
Magremanne M, Reychler H. Pentoxifylline and tocopherol in the treatment of yearly zoledronic acid-related osteonecrosis of the jaw in a corticosteroid-induced osteoporosis. J Oral Maxillofac Surg 2014;72:334-337.
Baraldi A, Fusco V, Bellora A, et al. Prevention of bisphosphonatesinduced osteonecrosis. Clin Cases Miner Bone Metab 2007;4(1):58-61.
